[go: up one dir, main page]

CA2045950A1 - Vaccin recombinant pour la prevention ou le traitement d'infections causant des pleuropneumonies - Google Patents

Vaccin recombinant pour la prevention ou le traitement d'infections causant des pleuropneumonies

Info

Publication number
CA2045950A1
CA2045950A1 CA 2045950 CA2045950A CA2045950A1 CA 2045950 A1 CA2045950 A1 CA 2045950A1 CA 2045950 CA2045950 CA 2045950 CA 2045950 A CA2045950 A CA 2045950A CA 2045950 A1 CA2045950 A1 CA 2045950A1
Authority
CA
Canada
Prior art keywords
proteins
cytolytic
vaccine
prevention
pleuropneumoniae
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA 2045950
Other languages
English (en)
Other versions
CA2045950C (fr
Inventor
Elbarte M. Kamp
Marinus A. Smits
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centraal Diergeneeskundig Instituut
Original Assignee
Centraal Diergeneeskundig Instituut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centraal Diergeneeskundig Instituut filed Critical Centraal Diergeneeskundig Instituut
Priority to CA 2045950 priority Critical patent/CA2045950C/fr
Publication of CA2045950A1 publication Critical patent/CA2045950A1/fr
Application granted granted Critical
Publication of CA2045950C publication Critical patent/CA2045950C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CA 2045950 1991-06-28 1991-06-28 Vaccin recombinant pour la prevention ou le traitement d'infections causant des pleuropneumonies Expired - Fee Related CA2045950C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2045950 CA2045950C (fr) 1991-06-28 1991-06-28 Vaccin recombinant pour la prevention ou le traitement d'infections causant des pleuropneumonies

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2045950 CA2045950C (fr) 1991-06-28 1991-06-28 Vaccin recombinant pour la prevention ou le traitement d'infections causant des pleuropneumonies

Publications (2)

Publication Number Publication Date
CA2045950A1 true CA2045950A1 (fr) 1992-12-29
CA2045950C CA2045950C (fr) 2004-05-11

Family

ID=4147933

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2045950 Expired - Fee Related CA2045950C (fr) 1991-06-28 1991-06-28 Vaccin recombinant pour la prevention ou le traitement d'infections causant des pleuropneumonies

Country Status (1)

Country Link
CA (1) CA2045950C (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925354A (en) * 1995-11-30 1999-07-20 Michigan State University Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae
US6019984A (en) * 1995-03-01 2000-02-01 University Of Guelph Bacterial preparations, method for producing same, and their use as vaccines
US6610307B1 (en) * 1995-11-02 2003-08-26 Commonwealth Scientific And Industrial Research Organisation Immunity against pasteurella haemolytica leukotoxin
US6770275B1 (en) * 1996-05-31 2004-08-03 Akzo Nobel N.V. Live attenuated RTC-producing bacteria of the family

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6019984A (en) * 1995-03-01 2000-02-01 University Of Guelph Bacterial preparations, method for producing same, and their use as vaccines
US6610307B1 (en) * 1995-11-02 2003-08-26 Commonwealth Scientific And Industrial Research Organisation Immunity against pasteurella haemolytica leukotoxin
US5925354A (en) * 1995-11-30 1999-07-20 Michigan State University Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae
US6410021B1 (en) 1995-11-30 2002-06-25 Univ Michigan State Vaccines of pasteurellaceae mutants and vaccination method
US6770275B1 (en) * 1996-05-31 2004-08-03 Akzo Nobel N.V. Live attenuated RTC-producing bacteria of the family

Also Published As

Publication number Publication date
CA2045950C (fr) 2004-05-11

Similar Documents

Publication Publication Date Title
EP1347055A3 (fr) Composés et procédés pour l'immunothérapie et le diagnostic de la tuberculose
CA2123579A1 (fr) Vaccin recombinant multivalent a proteine m
PT100781A (pt) Sequencias de dna codificadoras de proteinas de superficie externa, proteinas contendo as referidas sequencias, obtidas a partir de borrelia burgdorferi, e vacinas contendo as referidas proteinas
WO1999042588A3 (fr) Antigenes du streptocoque du groupe b
WO1998053075A3 (fr) Composes pour l'immunotherapie et pour le diagnostic de la tuberculose et leur utilisation
EP1275720A3 (fr) Histidyl-trna synthetase de staphylococcus aureus
EP1071451A4 (fr) Composes et methodes pour l'immunotherapie et le diagnostic de la tuberculose
AU6236396A (en) Omp26 antigen from haemophilus influenzae
WO2003065973A3 (fr) Compositions de vaccins multivalents a base de streptocoques et procedes d'utilisation
NO974969D0 (no) Multimer rekombinant ureasevaksine
CA2105057A1 (fr) Sequences d'adn codant pour les caracteres de virulence de streptococcus suis et partie de ces sequences, polypeptides et anticorps derives de ces sequences et leur utilisation pour le diagnostic des infections a s. suis et la protection des mammiferes, y compris de l'homme, contre celles-ci
CA2045950A1 (fr) Vaccin recombinant pour la prevention ou le traitement d'infections causant des pleuropneumonies
CA2071863A1 (fr) Vaccin recombinant contre la pleuropneumonie porcine
CA2113562A1 (fr) Antigenes de mycoplasme de volaille, genes codant pour ces antigenes, vecteurs recombinants contenant ce gene et vaccins derives
AU5625796A (en) Protective epitopes of adenyl cyclase-haemolysin(AC-Hly), their application to the treatment or to the prevention of bordetella infections
FR2652266B1 (fr) Vaccin protecteur contre l'hemophilose porcine.
NZ331889A (en) Trypanosomatids histones for use as an antigen against trypanosomatic infection, including diagnostic tests, pharmaceutical compositions and vaccines of these antigens
WO2000046242A3 (fr) PROTEINE DE 19 KILODALTONS PRODUITE PAR LA BACTERIE $i(HELICOBACTER PYLORI)

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed